DEALS

Industry Buzz: The 10 Biggest DX Mergers of 2019

Conspicuous by its absence from the list is the proposed $1.2 billion Illumina takeover of Pacific Biosciences which suddenly seems to be in major trouble. Here are the 10-highest value M&A diagnostics deals that did come off in 2019.


Top 10 Lab M&A Deals of 2019

Rank Buyer Target Reported Price
1 Danaher GE Biopharma $21.4 billion
2 Exact Sciences Genomic Health $2.8 billion (cash + stock)
3 Thermo Fisher Scientific Brammer Bio $1.7 billion
4 Agilent Technologies BioTek Instruments $1.17 billion
5 PHC Holdings (formerly known as Panasonic Healthcare Holdings) Thermo Fisher Scientific $1.14 billion
6 Sartorius Danaher $750 million*
7 Covance Drug Development (part of LabCorp) Envigo $485 million
8 Beckman Coulter Life Sciences Labcyte $308 million
9 PerkinElmer Cisbio Bioassays $219.8 million
10  Clayton, Dubilier & Rice investment funds Cynosure (owned by Hologic) $205 million

* Announced in 2019 with closing scheduled for 2020

CLOSE TO VIEW ARTICLE x

You have 3 articles left to view this month.

Your 3 Free Articles Per Month Goes Very Quickly!
Get a 3 month Premium Membership to
one of our G2 Newsletters today!

Click on one of the Newsletters below to sign up now and get unlimited access to all articles, archives, and tools for that specific newsletter!

Close

EMAIL ADDRESS


PASSWORD
EMAIL ADDRESS

FIRST NAME

LAST NAME

TITLE

COMPANY

PHONE

Try Premium Membership

(-00000g2)